Every Day Your Dossier Stalls, Your Competitors Capture Your Market Share
Stop letting technical deficiencies kill your commercial window.
We provide elite pre-submission audits and deficiency rescue for ACTD, CTD, and eCTD submissions.
More than a checklist: We execute deep-dive forensic reviews through the lens of a Lead Assessor to neutralize scientific gaps and de-risk your asset before it ever hits the regulator’s desk.
Core Regulatory Expertise
We do not guess what the Health Authority wants; we know exactly how they evaluate. Founded and led by a former Health Authority Lead Assessor, Regustat bridges the critical gap between raw commercial data and strict regulatory reality.
We approach your CMC, Bioequivalence (BE), and Clinical data suites not as external consultants, but through the forensic lens of the agency reviewing them. By evaluating the core science of your ACTD, CTD, or eCTD submission exactly as an active regulator would, we anticipate queries and construct a scientifically defensible narrative built to withstand intense regulatory scrutiny.
The Regustat Advantage
While most agencies act as administrative pass-throughs, Regustat operates as a Technical Intelligence partner. We bridge the gap between raw manufacturer data and strict regulator demands by forensically mapping critical points of failure across your ACTD, CTD, and eCTD submissions. We don't just move documents; we provide the definitive technical roadmap to de-risk your asset before it ever reaches the Health Authority.
Technical Solutions
Strategic dossier architecture and rapid deficiency remediation for high-stakes approvals.
Submission De-risking
Exhaustive pre-submission diagnostics to identify critical CMC and clinical gaps. We ensure absolute structural integrity of your dossier to improve immediate pre-assessment acceptance by Health Authorities.
Deficiency Response & Rescue
Immediate technical intervention for critical deficiencies. We take unoptimized, raw supplier data and thoroughly re-architect it into a rigorous, regulator-approved format—eliminating friction and securing your commercial clearance.
Specialized regulatory mapping for biologicals, orphan drugs, and novel therapeutics. We execute forensic diagnostics on dense Bioequivalence (BE) and clinical data to forge a definitive market pathway for your most difficult products.
Complex Asset Architecture
Strategic Regulatory Intelligence and forensic technical audits for high-acuity pharmaceutical assets.
Data Integrity Notice:
All submissions are transmitted via encrypted channels and bound by institutional MNDA protocols. Regustat operates under strict professional governance for pharmaceutical compliance.
© 2026 Regustat. All rights reserved.